Edwards Lifesciences' (NYSE:EW) Conservative Accounting Might Explain Soft Earnings
Edwards Lifesciences Corp EW
$81.39
▲ +2.08%
(+$1.66)
Index member:
S&P 500
Open
$79.55
Prev Close
$79.73
Day Range
$78.29 – $81.73
52W Range
$72.30 – $87.89
Market Cap
$44.43B
P/E (TTM)
42.56
Beta
0.85
EPS (TTM)
$1.88
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 2000-03-27 |
| Shares Out. | 576,540,000 |
| Website | edwards.com ↗ |
| Phone | 13026587581 |
Edwards Lifesciences Corp is a publicly traded company under the ticker symbol EW on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
43 analysts (2026-05-01)
📰 Latest News for EW
Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Transcript : Edwards Lifesciences Corporation Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
Edwards Lifesciences (EW) is Benefitting from Expanding Its Aortic Valve Franchise
Edwards names Theodora Mistras as CFO
Edwards Lifesciences Announces Appointment of CFO
Possible Bearish Signals With Edwards Lifesciences Insiders Disposing Stock